tiprankstipranks
Entia Biosciences Inc (ERGO)
OTHER OTC:ERGO
US Market

Entia Biosciences (ERGO) Cash flow

6 Followers

Entia Biosciences Cash Flow

ERGO's free cash flow for Q was $-439.96K. For the fiscal year, ERGO's free cash flow was decreased by $-164.36K and operating cash flow was $-439.96K. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 16Dec 15Dec 14Dec 13Dec 12
Operating Cash Flow
$ -715.10K$ -715.10K$ -536.57K$ -680.28K$ -766.73K$ -314.60K
Investing Cash Flow
$ -7.12K$ -7.12K$ -21.29K$ -45.46K$ -64.60K$ -63.33K
Financing Cash Flow
$ 774.13K$ 774.13K$ 482.52K$ 788.32K$ 855.14K$ 374.36K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 95.83K$ 76.05K$ 24.13K$ 99.46K$ 36.89K$ 13.08K
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 6.75K$ 6.75K$ 37.83K$ 843.00$ 1.06K$ 5.64K
Issuance Of Capital Stock
-$ 0.00$ 560.17K$ 40.00K$ 700.88K$ 327.00K
Issuance Of Debt
$ 829.40K$ 829.40K$ 100.00K$ 606.50K$ 191.10K$ 47.36K
Repayment Of Debt
$ -55.27K$ -55.27K$ -177.65K$ -83.18K$ -36.83K-
Free Cash Flow
$ -722.22K$ -722.22K$ -557.85K$ -725.75K$ -831.34K$ -377.92K
Domestic Sales
------
Foreign Sales
------
Currency in USD

Entia Biosciences Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis